IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 53.67, with a low estimate of 27 and a high estimate of 68. The average target predicts an increase of 145.63% from the current stock price of 21.85.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$27	$53.67	$53	$68
Change	+23.57%	+145.63%	+142.56%	+211.21%

* Price targets were last updated on Jan 15, 2025.

Analyst Ratings

The average analyst rating for IDEAYA Biosciences stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	5	6	5	5	5	5
Buy	5	5	6	7	7	7
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	12	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza RBC Capital	RBC Capital	Buy Reiterates $61	Buy	Reiterates	$61	+179.18%	Jan 15, 2025
Li Watsek Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jan 13, 2025
Li Watsek Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Dec 17, 2024
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $52	Buy	Reiterates	$52	+137.99%	Dec 17, 2024
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Initiates $51	Buy	Initiates	$51	+133.41%	Nov 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

14.83M

Increased by 111.81%

from 7.00M

Revenue Next Year

50.49M

Increased by 240.55%

from 14.83M

EPS This Year

-2.87

from -3.36

EPS Next Year

-2.86

from -2.87

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	19.54M	27.94M	50.93M	23.39M	7.00M	14.83M	50.49M	171.07M
Revenue Growth	-	43.01%	82.28%	-54.08%	-70.07%	111.81%	240.55%	238.79%
EPS	-1.40	-1.41	-1.42	-1.96	-3.36	-2.87	-2.86	-2.75
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	14	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	45.2M	183.2M	225.2M
Avg	14.8M	50.5M	171.1M
Low	n/a	n/a	131.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	545.0%	1,135.5%	346.1%
Avg	111.8%	240.6%	238.8%
Low	-	-	159.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.47	-1.59	-2.03
Avg	-2.87	-2.86	-2.75
Low	-3.41	-3.98	-3.58

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.